Skip to main content

Table 3 Comparison of therapy outcome between two group

From: Exploring the efficacy of recombinant human pro-urokinase in catheter-directed thrombolysis for acute lower extremity deep venous thrombosis patients

Group

Observation Group

(n = 43)

Control Group

(n = 42)

χ2/Z/t

P value

clinical effective rate

    

Markedly Effective

28(65.12%)

20(47.62%)

  

Effective

13(30.23%)

12(28.57%)

  

Ineffective

2(4.65%)

10(23.81%)

  

Total Effective Rate

41(95.35%)

32(76.19%)

6.432

0.011

Treatment time (minute)

70.65 ± 15.44

82.67 ± 18.45

3.255

0.002

Hospitalization time(day)

8.99 ± 1.85

10.66 ± 2.57

3.437

0.001

Number of residual stenosis lesions

5.53 ± 2.77

7.56 ± 3.06

3.212

0.002

Venous Patency Rate (%)

80.86 ± 7.92

72.86 ± 11.87

3.648

<0.001